Matsushima Y et al. |
Distinct roles of prostaglandin D2 receptors in chronic skin inflammation. |
2011 |
Mol. Immunol. |
pmid:21943706
|
Papageorgiou E et al. |
Rosiglitazone attenuates insulin-like growth factor 1 receptor survival signaling in PC-3 cells. |
2008 Jul-Aug |
Mol. Med. |
pmid:18475308
|
Ashby B |
Novel mechanism of heterologous desensitization of adenylate cyclase: prostaglandins bind with different affinities to both stimulatory and inhibitory receptors on platelets. |
1990 |
Mol. Pharmacol. |
pmid:1695318
|
Sykes DA et al. |
Fevipiprant (QAW039), a Slowly Dissociating CRTh2 Antagonist with the Potential for Improved Clinical Efficacy. |
2016 |
Mol. Pharmacol. |
pmid:26916831
|
Tanaka Y et al. |
Hepatic ischemia-reperfusion induces renal heme oxygenase-1 via NF-E2-related factor 2 in rats and mice. |
2007 |
Mol. Pharmacol. |
pmid:17151289
|
Yagami T et al. |
Human group IIA secretory phospholipase A2 induces neuronal cell death via apoptosis. |
2002 |
Mol. Pharmacol. |
pmid:11752212
|
Hata AN et al. |
Structural determinants of arylacetic acid nonsteroidal anti-inflammatory drugs necessary for binding and activation of the prostaglandin D2 receptor CRTH2. |
2005 |
Mol. Pharmacol. |
pmid:15563582
|
Katura T et al. |
15-Deoxy-delta 12,14-prostaglandin J2 biphasically regulates the proliferation of mouse hippocampal neural progenitor cells by modulating the redox state. |
2010 |
Mol. Pharmacol. |
pmid:20086036
|
Mathiesen JM et al. |
On the mechanism of interaction of potent surmountable and insurmountable antagonists with the prostaglandin D2 receptor CRTH2. |
2006 |
Mol. Pharmacol. |
pmid:16418339
|
Lee SJ et al. |
Peroxisome proliferator-activated receptor-gamma and retinoic acid X receptor alpha represses the TGFbeta1 gene via PTEN-mediated p70 ribosomal S6 kinase-1 inhibition: role for Zf9 dephosphorylation. |
2006 |
Mol. Pharmacol. |
pmid:16611854
|
Rockwell CE et al. |
Interleukin-2 suppression by 2-arachidonyl glycerol is mediated through peroxisome proliferator-activated receptor gamma independently of cannabinoid receptors 1 and 2. |
2006 |
Mol. Pharmacol. |
pmid:16611855
|
Zhao G et al. |
Pivotal role of reactive oxygen species in differential regulation of lipopolysaccharide-induced prostaglandins production in macrophages. |
2013 |
Mol. Pharmacol. |
pmid:23071105
|
Raman P et al. |
15-Deoxy-delta12,14-prostaglandin J2-glycerol ester, a putative metabolite of 2-arachidonyl glycerol, activates peroxisome proliferator activated receptor gamma. |
2011 |
Mol. Pharmacol. |
pmid:21511917
|
Savinainen JR et al. |
Robust hydrolysis of prostaglandin glycerol esters by human monoacylglycerol lipase (MAGL). |
2014 |
Mol. Pharmacol. |
pmid:25140003
|
Miwa Y et al. |
15-Deoxy-Delta(12,14)-prostaglandin J(2) induces G(1) arrest and differentiation marker expression in vascular smooth muscle cells. |
2000 |
Mol. Pharmacol. |
pmid:10999955
|
Cuzzocrea S et al. |
The cyclopentenone prostaglandin 15-deoxy-Delta(12,14)-prostaglandin J(2) attenuates the development of acute and chronic inflammation. |
2002 |
Mol. Pharmacol. |
pmid:11961117
|
Chen ZY and Tseng CC |
15-deoxy-Delta12,14 prostaglandin J2 up-regulates Kruppel-like factor 4 expression independently of peroxisome proliferator-activated receptor gamma by activating the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signal transduction pathway in HT-29 colon cancer cells. |
2005 |
Mol. Pharmacol. |
pmid:16077033
|
Mix KS et al. |
Peroxisome proliferator-activated receptor-gamma-independent repression of collagenase gene expression by 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid and prostaglandin 15-deoxy-delta(12,14) J2: a role for Smad signaling. |
2004 |
Mol. Pharmacol. |
pmid:14742672
|
Ianaro A et al. |
Anti-inflammatory activity of 15-deoxy-delta12,14-PGJ2 and 2-cyclopenten-1-one: role of the heat shock response. |
2003 |
Mol. Pharmacol. |
pmid:12815164
|
Chung SW et al. |
Inhibition of interleukin-4 production in CD4+ T cells by peroxisome proliferator-activated receptor-gamma (PPAR-gamma) ligands: involvement of physical association between PPAR-gamma and the nuclear factor of activated T cells transcription factor. |
2003 |
Mol. Pharmacol. |
pmid:14573767
|
Fionda C et al. |
Inhibition of trail gene expression by cyclopentenonic prostaglandin 15-deoxy-delta12,14-prostaglandin J2 in T lymphocytes. |
2007 |
Mol. Pharmacol. |
pmid:17673570
|
Stillman BA et al. |
Importance of the extracellular domain for prostaglandin EP(2) receptor function. |
1999 |
Mol. Pharmacol. |
pmid:10462542
|
Ciucci A et al. |
Induction of apoptosis in estrogen receptor-negative breast cancer cells by natural and synthetic cyclopentenones: role of the IkappaB kinase/nuclear factor-kappaB pathway. |
2006 |
Mol. Pharmacol. |
pmid:16908599
|
Sánchez-Gómez FJ et al. |
Protein thiol modification by 15-deoxy-Delta12,14-prostaglandin J2 addition in mesangial cells: role in the inhibition of pro-inflammatory genes. |
2004 |
Mol. Pharmacol. |
pmid:15317873
|
Jung KM et al. |
Activation of p38 mitogen-activated protein kinase and activator protein-1 during the promotion of neurite extension of PC-12 cells by 15-deoxy-delta12,14-prostaglandin J2. |
2003 |
Mol. Pharmacol. |
pmid:12606768
|
Berry EB et al. |
Nanomolar and micromolar effects of 15-deoxy-delta 12,14-prostaglandin J2 on amnion-derived WISH epithelial cells: differential roles of peroxisome proliferator-activated receptors gamma and delta and nuclear factor kappa B. |
2005 |
Mol. Pharmacol. |
pmid:15821150
|
Bai YJ et al. |
A LC-MS-based method for quantification of biomarkers from serum of allergic rats. |
2010 |
Molecules |
pmid:20657485
|
Wojno ED et al. |
The prostaglandin Dâ‚‚ receptor CRTH2 regulates accumulation of group 2 innate lymphoid cells in the inflamed lung. |
2015 |
Mucosal Immunol |
pmid:25850654
|
Satoh K et al. |
Lipid peroxidation end products-responded induction of a preneoplastic marker enzyme glutathione S-transferase P-form (GST-P) in rat liver on admistration via the portal vein. |
2001 |
Mutat. Res. |
pmid:11600134
|
Poynard T et al. |
Secretory diarrhea and prostaglandin D2 overproduction in systemic mastocytosis. |
1982 |
N. Engl. J. Med. |
pmid:6953312
|
Laidlaw TM and Boyce JA |
Aspirin-Exacerbated Respiratory Disease--New Prime Suspects. |
2016 |
N. Engl. J. Med. |
pmid:26840139
|
Knapp HR |
Reduced allergen-induced nasal congestion and leukotriene synthesis with an orally active 5-lipoxygenase inhibitor. |
1990 |
N. Engl. J. Med. |
pmid:1701029
|
Forman MB et al. |
Increased adventitial mast cells in a patient with coronary spasm. |
1985 |
N. Engl. J. Med. |
pmid:2413358
|
Goetzl EJ |
Asthma: new mediators and old problems. |
1984 |
N. Engl. J. Med. |
pmid:6330554
|
Naclerio RM et al. |
Inflammatory mediators in late antigen-induced rhinitis. |
1985 |
N. Engl. J. Med. |
pmid:2582257
|
Murray JJ et al. |
Release of prostaglandin D2 into human airways during acute antigen challenge. |
1986 |
N. Engl. J. Med. |
pmid:3462506
|
Wingard CJ et al. |
Mast cells contribute to altered vascular reactivity and ischemia-reperfusion injury following cerium oxide nanoparticle instillation. |
2011 |
Nanotoxicology |
pmid:21043986
|
Pettipher R et al. |
Antagonism of the prostaglandin D2 receptors DP1 and CRTH2 as an approach to treat allergic diseases. |
2007 |
Nat Rev Drug Discov |
pmid:17396136
|
Taketomi Y et al. |
Mast cell maturation is driven via a group III phospholipase A2-prostaglandin D2-DP1 receptor paracrine axis. |
2013 |
Nat. Immunol. |
pmid:23624557
|
Starkl P et al. |
PLA2G3 promotes mast cell maturation and function. |
2013 |
Nat. Immunol. |
pmid:23685814
|
Gilroy DW et al. |
Inducible cyclooxygenase may have anti-inflammatory properties. |
1999 |
Nat. Med. |
pmid:10371510
|
Wang C et al. |
A chemoproteomic platform to quantitatively map targets of lipid-derived electrophiles. |
2014 |
Nat. Methods |
pmid:24292485
|
Luster AD and Tager AM |
T-cell trafficking in asthma: lipid mediators grease the way. |
2004 |
Nat. Rev. Immunol. |
pmid:15343370
|
Ricote M et al. |
The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. |
1998 |
Nature |
pmid:9422508
|
Jiang C et al. |
PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. |
1998 |
Nature |
pmid:9422509
|
Rossi A et al. |
Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase. |
2000 |
Nature |
pmid:10638762
|
Wang JP et al. |
Anti-inflammatory and analgesic effects of magnolol. |
1992 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:1336574
|
Molderings GJ et al. |
Modulation of noradrenaline release from the sympathetic nerves of human right atrial appendages by presynaptic EP3- and DP-receptors. |
1998 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:9826066
|
Featherstone RL et al. |
Evidence for thromboxane receptor mediated contraction of guinea-pig and human airways in vitro by prostaglandin (PG) D2, 9 alpha,11 beta-PGF2 and PGF2 alpha. |
1990 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:2142256
|
Hsu MF et al. |
Inhibition of the arachidonic acid cascade by norathyriol via blockade of cyclooxygenase and lipoxygenase activity in neutrophils. |
2004 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:15083266
|
Prakash J et al. |
Albumin-binding and tumor vasculature determine the antitumor effect of 15-deoxy-Delta-(12,14)-prostaglandin-J(2) in vivo. |
2009 |
Neoplasia |
pmid:20019843
|
Lee S et al. |
Rosiglitazone ameliorates cisplatin-induced renal injury in mice. |
2006 |
Nephrol. Dial. Transplant. |
pmid:16728429
|
Li X et al. |
Hypoxia reduces the expression and anti-inflammatory effects of peroxisome proliferator-activated receptor-gamma in human proximal renal tubular cells. |
2007 |
Nephrol. Dial. Transplant. |
pmid:17255125
|
Panzer U et al. |
15-deoxy-Delta12,14-prostaglandin J2 inhibits INF-gamma-induced JAK/STAT1 signalling pathway activation and IP-10/CXCL10 expression in mesangial cells. |
2008 |
Nephrol. Dial. Transplant. |
pmid:18596134
|
Kimura H et al. |
A natural PPAR-gamma agonist, 15-deoxy-delta 12,14-prostaglandin J2, may act as an enhancer of PAI-1 in human proximal renal tubular cells under hypoxic and inflammatory conditions. |
2008 |
Nephrol. Dial. Transplant. |
pmid:18367541
|
Lu Y et al. |
15-Deoxy-Δ(12,14)-prostaglandin J(2) modulates lipopolysaccharide-induced chemokine expression by blocking nuclear factor-κB activation via peroxisome proliferator activated receptor-γ-independent mechanism in renal tubular epithelial cells. |
2013 |
Nephron Exp. Nephrol. |
pmid:23887394
|
Kootte AM et al. |
The flush syndrome: an expression of systemic mastocytosis with increased prostaglandin D2 production. |
1983 |
Neth J Med |
pmid:6572798
|
Flores JJ et al. |
PPARγ-induced upregulation of CD36 enhances hematoma resolution and attenuates long-term neurological deficits after germinal matrix hemorrhage in neonatal rats. |
2016 |
Neurobiol. Dis. |
pmid:26739391
|
Ogburn KD et al. |
Prostaglandin J2 reduces catechol-O-methyltransferase activity and enhances dopamine toxicity in neuronal cells. |
2006 |
Neurobiol. Dis. |
pmid:16406650
|
Liu H et al. |
Modification of ubiquitin-C-terminal hydrolase-L1 by cyclopentenone prostaglandins exacerbates hypoxic injury. |
2011 |
Neurobiol. Dis. |
pmid:20933087
|
Naffah-Mazzacoratti MG et al. |
Profile of prostaglandin levels in the rat hippocampus in pilocarpine model of epilepsy. |
1995 |
Neurochem. Int. |
pmid:8574174
|
Cho WH et al. |
15-deoxy-(Delta12,14)-prostaglandin J2 (15d-PGJ2) induces cell death through caspase-independent mechanism in A172 human glioma cells. |
2006 |
Neurochem. Res. |
pmid:17006759
|
Gotoh M et al. |
Desensitization of prostaglandin F2 alpha receptor-mediated phosphoinositide hydrolysis in cultured rat astrocytes. |
1994 |
Neurochem. Res. |
pmid:8065525
|
Tsuji T et al. |
Reduction of nuclear peroxisome proliferator-activated receptor gamma expression in methamphetamine-induced neurotoxicity and neuroprotective effects of ibuprofen. |
2009 |
Neurochem. Res. |
pmid:18946735
|
Li W et al. |
Neuronal cyclooxygenase-2 activity and prostaglandins PGE2, PGD2, and PGF2 alpha exacerbate hypoxic neuronal injury in neuron-enriched primary culture. |
2008 |
Neurochem. Res. |
pmid:17763946
|
Urade Y et al. |
Sleep regulation in adenosine A2A receptor-deficient mice. |
2003 |
Neurology |
pmid:14663019
|
Dore-Duffy P et al. |
Cerebrospinal fluid eicosanoid levels: endogenous PGD2 and LTC4 synthesis by antigen-presenting cells that migrate to the central nervous system. |
1991 |
Neurology |
pmid:1992386
|
Kaneko K et al. |
Novel orexigenic pathway prostaglandin D2-NPY system--involvement in orally active orexigenic δ opioid peptide. |
2012 |
Neuropeptides |
pmid:23141054
|
Bate C et al. |
Prostaglandin D2 mediates neuronal damage by amyloid-beta or prions which activates microglial cells. |
2006 |
Neuropharmacology |
pmid:16289250
|
Grill M et al. |
Systemic inflammation induces COX-2 mediated prostaglandin D2 biosynthesis in mice spinal cord. |
2006 |
Neuropharmacology |
pmid:16182321
|
Costello DA et al. |
Agonists of peroxisome proliferator-activated receptor-gamma attenuate the Abeta-mediated impairment of LTP in the hippocampus in vitro. |
2005 |
Neuropharmacology |
pmid:15993441
|
Morgenweck J et al. |
Activation of peroxisome proliferator-activated receptor gamma in brain inhibits inflammatory pain, dorsal horn expression of Fos, and local edema. |
2010 |
Neuropharmacology |
pmid:19891980
|
GarcÃa-Bueno B et al. |
Effects of peroxisome proliferator-activated receptor gamma agonists on brain glucose and glutamate transporters after stress in rats. |
2007 |
Neuropsychopharmacology |
pmid:17119541
|
Rohn TT et al. |
15-deoxy-delta12,14-prostaglandin J2, a specific ligand for peroxisome proliferator-activated receptor-gamma, induces neuronal apoptosis. |
2001 |
Neuroreport |
pmid:11277593
|
Yoshida Y et al. |
Prostaglandin E (EP) receptor subtypes and sleep: promotion by EP4 and inhibition by EP1/EP2. |
2000 |
Neuroreport |
pmid:10923657
|
Terao A et al. |
Enhancement of slow-wave sleep by tumor necrosis factor-alpha is mediated by cyclooxygenase-2 in rats. |
1998 |
Neuroreport |
pmid:9875706
|
Horváth B et al. |
Carbon monoxide-prostaglandin E2 interaction in the hypothalamic circulation. |
2008 |
Neuroreport |
pmid:18815586
|
Govoni S et al. |
The Cycloxygenase-2 inhibitor SC58236 is neuroprotective in an in vivo model of focal ischemia in the rat. |
2001 |
Neurosci. Lett. |
pmid:11311500
|
Leamy AW et al. |
Curcumin ((E,E)-1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione) activates and desensitizes the nociceptor ion channel TRPA1. |
2011 |
Neurosci. Lett. |
pmid:21855605
|
Nakae K et al. |
Functional role of prostacyclin receptor in rat dorsal root ganglion neurons. |
2005 |
Neurosci. Lett. |
pmid:16039053
|
Wu L et al. |
Divergent effects of prostaglandin receptor signaling on neuronal survival. |
2007 |
Neurosci. Lett. |
pmid:17574754
|
Kitamura Y et al. |
Activators of peroxisome proliferator-activated receptor-gamma (PPARgamma) inhibit inducible nitric oxide synthase expression but increase heme oxygenase-1 expression in rat glial cells. |
1999 |
Neurosci. Lett. |
pmid:10203248
|
Marchini C et al. |
Aspirin modulates LPS-induced nitric oxide release in rat glial cells. |
2005 Jun 10-17 |
Neurosci. Lett. |
pmid:15882795
|
Ott D et al. |
Prostaglandin D2 modulates calcium signals induced by prostaglandin E2 in neurons of rat dorsal root ganglia. |
2015 |
Neurosci. Lett. |
pmid:25912777
|
Myeku N et al. |
cAMP stimulates the ubiquitin/proteasome pathway in rat spinal cord neurons. |
2012 |
Neurosci. Lett. |
pmid:22982149
|
Inoué S et al. |
Little sleep-promoting effect of three sleep substances diurnally infused in unrestrained rats. |
1984 |
Neurosci. Lett. |
pmid:6593603
|
Satoh S et al. |
Promotion of sleep by prostaglandin D2 in rats made insomniac by pretreatment with para-chlorophenylalanine. |
1994 |
Neurosci. Res. |
pmid:7708292
|
Osaka T and Hayaishi O |
Prostaglandin D2 modulates sleep-related and noradrenaline-induced activity of preoptic and basal forebrain neurons in the rat. |
1995 |
Neurosci. Res. |
pmid:8545074
|
Vesin MF et al. |
Biosynthesis of prostaglandin D2 by motoneurons and dorsal horn microneurons: a biochemical and high resolution immunocytochemical study in chick spinal cord. |
1995 |
Neuroscience |
pmid:8596663
|
Liu M et al. |
Focal cerebral ischemia/reperfusion injury in mice induces hematopoietic prostaglandin D synthase in microglia and macrophages. |
2007 |
Neuroscience |
pmid:17241746
|
Telleria-Diaz A et al. |
Different effects of spinally applied prostaglandin D2 on responses of dorsal horn neurons with knee input in normal rats and in rats with acute knee inflammation. |
2008 |
Neuroscience |
pmid:18678231
|
Zurich MG et al. |
Unusual astrocyte reactivity caused by the food mycotoxin ochratoxin A in aggregating rat brain cell cultures. |
2005 |
Neuroscience |
pmid:15994020
|
Pena-dos-Santos DR et al. |
Activation of peripheral kappa/delta opioid receptors mediates 15-deoxy-(Delta12,14)-prostaglandin J2 induced-antinociception in rat temporomandibular joint. |
2009 |
Neuroscience |
pmid:19647045
|
Horiguchi T et al. |
Cyclooxygenase-2 mediates the development of cortical spreading depression-induced tolerance to transient focal cerebral ischemia in rats. |
2006 |
Neuroscience |
pmid:16567054
|
Hayaishi O and Urade Y |
Prostaglandin D2 in sleep-wake regulation: recent progress and perspectives. |
2002 |
Neuroscientist |
pmid:11843094
|
Shohami E et al. |
Experimental closed head injury in rats: prostaglandin production in a noninjured zone. |
1988 |
Neurosurgery |
pmid:3164097
|
Liu H et al. |
Prostaglandin D2 toxicity in primary neurons is mediated through its bioactive cyclopentenone metabolites. |
2013 |
Neurotoxicology |
pmid:23973622
|
Toscano CD et al. |
NMDA-induced seizure intensity is enhanced in COX-2 deficient mice. |
2008 |
Neurotoxicology |
pmid:18834901
|
Sakai T |
[Molecular cancer epidemiology--the present status and future possibilities]. |
1996 |
Nihon Eiseigaku Zasshi |
pmid:8720930
|
Nishimura G |
[Antitumor activity and cell cycle effects of delta 12-PGJ2 in vivo]. |
1990 |
Nihon Gan Chiryo Gakkai Shi |
pmid:2351856
|